Skip to main content
. 2021 Feb 2;11:2792. doi: 10.1038/s41598-021-82502-y

Figure 7.

Figure 7

Bone volume fraction distribution after 540 days of simulation for different doses of (a) 0.1, (b) 0.3, (c) 1.0, (d) 3.0 mg/kg of denosumab and doses of (e) 0.25, (f) 0.5, (g) 1.0, (h) 2.0 mg of bisphosphonates and (i) control implant.